GH Research PLC (GHRS) Financials

GHRS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 372.3 million 12.9 million
March 31, 2026 275.3 million 11.9 million
Dec. 31, 2025 288.2 million 8.5 million
Sept. 30, 2025 302.0 million 10.6 million

GHRS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -15.0 million 2.2 million
March 31, 2026 -10.7 million 1.8 million
Dec. 31, 2025 -12.3 million 2.7 million
Sept. 30, 2025 -14.5 million 2.3 million

GHRS Net Income

No data available :(

GHRS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 362.7 million - 360000
March 31, 2026 267.3 million - 432000
Dec. 31, 2025 280.7 million - 147000
Sept. 30, 2025 288.5 million - 582000

GHRS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 66.5 million
March 31, 2026 62.0 million
Dec. 31, 2025 62.0 million
Sept. 30, 2025 62.0 million

GHRS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 17000 12.4 million 7.1 million -
March 31, 2026 63000 12.4 million 6.3 million -
Dec. 31, 2025 18091 11.4 million 5.2 million -
Sept. 30, 2025 41266 10.6 million 5.9 million -

GHRS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 90999
Dec. 31, 2025 - 87999
Sept. 30, 2025 - 89000

GHRS

Price: $29.49

52 week price:
11.32
31.44

Earnings Per Share: -1.03 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Ireland

Volume: 6316

Market Capitalization: 2.1 billion

Links: